Mediwelcome Healthcare Management & Technology Inc. (2159.HK)
HKD 0.43
(0.0%)
HKD 0.43
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -75.58 Million | -18.45 Million | 262 Thousand | 31.12 Million | 4.51 Million | 58.83 Million |
| Net Income | -96.37 Million | -91.03 Million | 5.58 Million | 22.28 Million | 25.97 Million | 49.15 Million |
| Depreciation & Amortization | 20.54 Million | 20.7 Million | 19.49 Million | 17.7 Million | 10.72 Million | 8.3 Million |
| Deferred income taxes | - | - | -11.66 Million | - | - | - |
| Stock-based compensation | -700 Thousand | 6.82 Million | 14.45 Million | - | - | - |
| Change in working capital | -22.22 Million | 42.8 Million | -28.08 Million | -6.06 Million | -29.22 Million | 6.19 Million |
| Other non-cash items | -900 Thousand | 2.24 Million | 465 Thousand | -2.8 Million | -2.96 Million | -4.81 Million |
| Investing Cash Flow | 16.45 Million | -8.35 Million | -16.76 Million | -10.98 Million | -24.52 Million | -30.38 Million |
| Investments in PPE | -1.6 Million | -4.29 Million | -24.99 Million | -13.81 Million | -12.99 Million | -5.16 Million |
| Acquisitions | - | - | 22.67 Million | 8.78 Million | -24 Thousand | 6.71 Million |
| Investment purchases | -19.99 Million | -107 Million | -172 Million | -16 Million | -70 Million | -17.99 Million |
| Sales/Maturities of investments | 37.64 Million | 102.31 Million | 179.43 Million | 18.41 Million | 54.01 Million | 5.68 Million |
| Other Investing Activities | 17.85 Million | 623 Thousand | -21.88 Million | -8.37 Million | 4.48 Million | -19.61 Million |
| Financing Cash Flow | 906 Thousand | 54 Thousand | 92.84 Million | -4.79 Million | -5.55 Million | -19.47 Million |
| Debt repayment | -12.41 Million | -7.78 Million | -4.5 Million | -3.89 Million | -5.24 Million | -5.41 Million |
| Dividends payments | - | - | - | - | - | -13.75 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 98.6 Million | - | - | - |
| Other Financing Activities | 11.11 Million | 7.84 Million | -1.25 Million | -896 Thousand | -309 Thousand | -5.72 Million |
| Accounts receivables | 14.05 Million | 4.14 Million | 1.81 Million | -7.75 Million | -47.04 Million | -4.41 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -16.19 Million | 38.65 Million | -29.89 Million | 1.69 Million | 17.82 Million | -946 Thousand |
| Cash at beginning of period | 138.57 Million | 165.32 Million | 88.99 Million | 73.64 Million | 99.2 Million | 90.21 Million |
| Cash at end of period | 80.35 Million | 138.57 Million | 165.32 Million | 88.99 Million | 73.64 Million | 99.2 Million |
| Capital Expenditure | -1.6 Million | -4.29 Million | -24.99 Million | -13.81 Million | -12.99 Million | -5.16 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -58.21 Million | -26.75 Million | 76.33 Million | 15.34 Million | -25.56 Million | 8.98 Million |
| Free Cash Flow | -77.18 Million | -22.75 Million | -24.73 Million | 17.31 Million | -8.48 Million | 53.67 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.1 Million | -11.1 Million | -96.37 Million | -29.24 Million | -29.24 Million | -17.8 Million |
| Depreciation & Amortization | 1.86 Million | 1.86 Million | 20.54 Million | 4.65 Million | -504 Thousand | 5.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | -700 Thousand | -700 Thousand | -700 Thousand | 350 Thousand |
| Change in working capital | - | - | -22.22 Million | -1.07 Million | -1.07 Million | - |
| Other non-cash items | 6.76 Million | 6.76 Million | -900 Thousand | -7.29 Million | -2.13 Million | 7.7 Million |
| Investing Cash Flow | 5.74 Million | 5.74 Million | 16.45 Million | 31.17 Million | 31.17 Million | -22.94 Million |
| Investments in PPE | -469.5 Thousand | -469.5 Thousand | -1.6 Million | -518.49 Thousand | -518.49 Thousand | -182 Thousand |
| Acquisitions | - | - | - | - | - | 22.76 Million |
| Investment purchases | - | - | -19.99 Million | - | - | -136.94 Million |
| Sales/Maturities of investments | - | - | 37.64 Million | - | - | 85.09 Million |
| Other Investing Activities | 6.21 Million | 6.21 Million | 17.85 Million | 31.69 Million | 31.69 Million | -22.76 Million |
| Financing Cash Flow | -2.22 Million | -2.22 Million | 906 Thousand | -4.6 Million | -4.6 Million | 5.05 Million |
| Debt repayment | - | - | -12.41 Million | - | - | -17.76 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.22 Million | -2.22 Million | 11.11 Million | -4.6 Million | -4.6 Million | 5.05 Million |
| Accounts receivables | - | - | 14.05 Million | 7.02 Million | 7.02 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | -16.19 Million | -8.09 Million | -8.09 Million | - |
| Cash at beginning of period | - | - | 138.57 Million | - | - | 155.57 Million |
| Cash at end of period | 1.04 Million | 1.04 Million | 80.35 Million | -7.08 Million | -7.08 Million | 101.97 Million |
| Capital Expenditure | -469.5 Thousand | -469.5 Thousand | -1.6 Million | -518.49 Thousand | -518.49 Thousand | -182 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | -31.58 Million |
| Net cash flow / Change in cash | 1.04 Million | 1.04 Million | -58.21 Million | -7.08 Million | -7.08 Million | -53.6 Million |
| Free Cash Flow | -2.94 Million | -2.94 Million | -77.18 Million | -34.17 Million | -34.17 Million | -4.31 Million |
A04
8614
8020
LGND
SFIIF
AKA